Report: Companies Stand to Make Billions Off Coronavirus Booster Shots | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

Report: Companies Stand to Make Billions Off Coronavirus Booster Shots

The advent of coronavirus booster shots could rake in billions of dollars in profits for companies like Pfizer and Moderna, according to the Associated Press (AP).

“Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus,” reported the AP. “How much the manufacturers stand to gain depends on how big the rollout proves to be.”

Though the U.S. Food and Drug Administration (FDA) has only approved the Pfizer booster shot for Americans 65 and older as well as high-risk Americans, experts predict booster shots will soon be available for all Americans, which will include products from Moderna and Johnson & Johnson. With that comes big profits, especially when factoring in that companies will not have the same massive overhead costs of research and development as the initial shots. Currently, the average forecast among Wall Street analysts for “Moderna’s 2022 revenue has jumped 35% since President Joe Biden laid out his booster plan in mid-August,” according to the AP.

“The opportunity quite frankly is reflective of the billions of people around the world who would need a vaccination and a boost,” Jefferies analyst Michael Yee told the outlet.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA